Insys Therapeutics says did not 'materially contribute' to opioid crisis
Insys Therapeutics released the following statement: "Like so many stakeholders in the healthcare community and in the government, we share the desire to address the serious national challenge related to the misuse and abuse of opioids that has led to addiction and unnecessary deaths and has caused so much pain to families and communities around the country. Our recent settlement with the State of Illinois, which includes an obligation to make a $4.45 million payment, reflects our firm commitment to take responsibility for actions by our former employees and we affirm our continued intent to put patients first as reflected by our actions and ethical behavior. With that in mind, we do not believe it is factually accurate to state that Insys has materially contributed to the opioid crisis in the State of Illinois or the nation. As the healthcare community and the government seek solutions to our national opioid crisis, it can be disheartening when this dialogue on this extremely important topic disregards the enormous amount of data and other facts available to all stakeholders. It is our hope that Insys can focus on solution-based initiatives regarding the opioid crisis such as developing alternative pain medications, increasing physician and patient education on appropriate use of scheduled products and coordinating on monitoring systems where there is ample evidence that these initiatives will reduce the incidence of abuse, addiction and overdose. We are committed to playing a productive role in solutions as is reflected in our investment and efforts in research and development and educational programs."